title: Development of new generation influenza vaccines: recipes for success?
abstract: As infectious diseases cause approximately 25% of the annual global mortality, vaccines are found to be a time proven and promising response to infectious disease need. However, like for pharmaceutical small molecules, vaccine development is lengthy, risky and resource demanding. Faced with an attrition rate estimated around 80%, key opinion leaders were interviewed with the question: is there a recipe for success?
authors.affiliation: Vacceleron, Jenalaan 18c, 3584 CK Utrecht, The Netherlands. e.s.pronker@gmail.com
authors.forename: E S
authors.initials: ES
authors.lastname: Pronker
authors.forename: E
authors.initials: E
authors.lastname: Claassen
authors.forename: A D M E
authors.initials: AD
authors.lastname: Osterhaus
mesh_terms: D000956:Antigens, Viral / Q000235:genetics / Q000276:immunology*; D055808:Drug Discovery / Q000639:trends; D006801:Humans; D007252:Influenza Vaccines / Q000235:genetics / Q000276:immunology*; D007251:Influenza, Human / Q000517:prevention & control* / Q000821:virology
chemical_list: D000956:Antigens, Viral; D007252:Influenza Vaccines